
Researchers have identified a new target for treating atrial fibrillation (AFib), a common heart rhythm disorder that significantly increases stroke risk. The study focuses on small-conductance calcium-activated potassium (SK2) channels, regulated by the lipid PIP2. By using advanced experimental and computational techniques, the team discovered how PIP2 affects SK2 channel function, offering insights for new treatment approaches. As SK channels are linked to heart failure, this discovery opens the door to potential therapeutic solutions for AFib and related cardiovascular diseases.
Like
Save
Share